Galectin 3
-
Subject Areas on Research
- A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial.
- Analogs of tetrahydroisoquinoline natural products that inhibit cell migration and target galectin-3 outside of its carbohydrate-binding site.
- Are existing and emerging biomarkers associated with cardiorespiratory fitness in patients with chronic heart failure?
- Association of Galectin-3 With Diabetes Mellitus in the Dallas Heart Study.
- Biomarker-based risk prediction in the community.
- Biomarkers for the Prevention of Heart Failure: Are We There Yet?
- Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure.
- Biomarkers, mineralocorticoid receptor antagonism, and cardiorenal remodeling.
- Circulating galectin-3 in infections and non-infectious inflammatory diseases.
- Effect of compressive force on unbinding specific protein-ligand complexes with force spectroscopy.
- Effect of high-intensity interval training on muscle remodeling in rheumatoid arthritis compared to prediabetes.
- Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma.
- Galectin-3 Associated with Severe Forms and Long-term Mortality in Patients with Chagas Disease.
- Galectin-3 and mineralocorticoid receptor antagonist use in patients with chronic heart failure due to left ventricular systolic dysfunction.
- Galectin-3 directs antimicrobial guanylate binding proteins to vacuoles furnished with bacterial secretion systems.
- Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study.
- Galectin-3 in heart failure with preserved ejection fraction. A RELAX trial substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure).
- Galectin-3 in heart failure: more answers or more questions?
- Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community.
- Guanylate Binding Proteins Regulate Inflammasome Activation in Response to Hyperinjected Yersinia Translocon Components.
- Lack of galectin-1 or galectin-3 alters B cell deletion and anergy in an autoantibody transgene model.
- Multimarker Risk Stratification in Patients With Acute Myocardial Infarction.
- Relationship between galectin-3 levels and mineralocorticoid receptor antagonist use in heart failure: analysis from HF-ACTION.
- Synephrine Hydrochloride Suppresses Esophageal Cancer Tumor Growth and Metastatic Potential through Inhibition of Galectin-3-AKT/ERK Signaling.
-
Keywords of People
- Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
- O'Connor, Christopher Michael, Richard Sean Stack, M.D. Distinguished Professor, Medicine, Clinical Pharmacology